HMS
FATE icon

Hanseatic Management Services’s Fate Therapeutics FATE Stock Holding History

Hanseatic Management Services’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65
Closed -$5K – 156
2021
Q1 		$5K Hold
65
– – 0.01% 143
2020
Q4 		$6K Sell
65
-94
-59% -$5.84K 0.01% 133
2020
Q3 		$6K Buy
159
+55
+53% +$1.92K 0.01% 154
2020
Q2 		$4K Hold
104
– – ﹤0.01% 154
2020
Q1 		$2K Buy
+104
New +$2.63K ﹤0.01% 184

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hanseatic Management Services's FATE Position: Q2 2021 in Review

Hanseatic Management Services sold out of Fate Therapeutics (FATE) in Q2 2021, closing a stake of 65 shares — an estimated $5K sold.

Hanseatic Management Services first reported a position in FATE in Q1 2020 and held it in 5 quarters. The position peaked at $6K in Q4 2020. 272 funds tracked by Wall St. Rank hold FATE as of Q2 2021.

  • Hanseatic Management Services reported no remaining Fate Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 65 Fate Therapeutics shares in Q2 2021, an estimated $5K.
  • Hanseatic Management Services first reported a position in Fate Therapeutics in Q1 2020 and held it in 5 quarters.
  • Hanseatic Management Services's Fate Therapeutics position peaked at $6K in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2021.

Based on Hanseatic Management Services's 13F filing for Q2 2021, filed 30 Jul 2021.